MARSHALL WACE, LLP - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 227 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$518,895
-87.6%
19,042
-89.9%
0.00%
-87.5%
Q2 2023$4,174,679
+57.8%
187,626
+53.6%
0.01%
+33.3%
Q1 2023$2,645,249
+251.3%
122,126
+315.8%
0.01%
+200.0%
Q3 2022$753,000
-42.4%
29,372
-46.6%
0.00%
-33.3%
Q2 2022$1,307,000
+496.8%
54,968
+452.9%
0.00%
+200.0%
Q2 2021$219,000
-80.1%
9,941
-78.5%
0.00%
-80.0%
Q1 2021$1,101,000
-83.3%
46,278
-81.6%
0.01%
-86.1%
Q4 2020$6,577,000
-31.3%
251,400
-54.3%
0.04%
-41.0%
Q3 2020$9,578,000
+49.6%
550,082
+2.1%
0.06%
-4.7%
Q1 2020$6,403,000
+873.1%
538,555
+890.4%
0.06%
+1180.0%
Q4 2019$658,000
-84.0%
54,377
-81.3%
0.01%
-84.4%
Q3 2019$4,100,000
+21.2%
290,186
-4.4%
0.03%
+14.3%
Q2 2019$3,384,000
-43.0%
303,504
-40.0%
0.03%0.0%
Q1 2019$5,940,000
-22.5%
505,962
-11.8%
0.03%
-64.1%
Q4 2018$7,667,000
+133.2%
573,836
+144.7%
0.08%
+457.1%
Q3 2018$3,288,000234,5040.01%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,370,017$181,2959.31%
Novo Holdings A/S 3,377,768$73,162,4554.83%
Parallel Advisors, LLC 3,724,573$80,674,2512.72%
TANAKA CAPITAL MANAGEMENT INC 35,539$7702.24%
Shay Capital LLC 350,000$7,581,0001.49%
Shay Capital LLC 350,000$7,581,0001.49%
S&T BANK/PA 350,924$7,6011.37%
Birchview Capital, LP 50,000$1,0830.85%
Clearview Wealth Advisors LLC 34,275$742,3970.75%
Granite Investment Partners, LLC 795,076$17,221,3460.72%
View complete list of CORCEPT THERAPEUTICS INC shareholders